SIGHT SCIENCES, INC. Increase (Decrease) in Employee Related Liabilities
SIGHT SCIENCES, INC. (SGHT) reported Increase (Decrease) in Employee Related Liabilities of -$1.41 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2026-08-05
- SIGHT SCIENCES, INC. increase (decrease) in employee related liabilities for the quarter ending 2026-06-30 was $975.00K, a 865.35% increase year-over-year.
- SIGHT SCIENCES, INC. increase (decrease) in employee related liabilities for the quarter ending 2026-03-31 was -$2.38M.
- SIGHT SCIENCES, INC. increase (decrease) in employee related liabilities for the quarter ending 2025-12-31 was -$118.00K, a 106.59% decline year-over-year.
- SIGHT SCIENCES, INC. increase (decrease) in employee related liabilities for the quarter ending 2025-09-30 was $965.00K, a 61.31% decline year-over-year.
- SIGHT SCIENCES, INC. increase (decrease) in employee related liabilities for fiscal 2025 was -$3.61M, a 170.01% decline from fiscal 2024.
- SIGHT SCIENCES, INC. increase (decrease) in employee related liabilities for fiscal 2024 was $5.15M.
- SIGHT SCIENCES, INC. increase (decrease) in employee related liabilities for fiscal 2023 was -$2.82M, a 306.96% decline from fiscal 2022.
- SIGHT SCIENCES, INC. increase (decrease) in employee related liabilities for fiscal 2022 was $1.36M, a 28.88% decline from fiscal 2021.
| Period end | Increase (Decrease) in Employee Related Liabilities 3 month | Increase (Decrease) in Employee Related Liabilities 6 month | Increase (Decrease) in Employee Related Liabilities 9 month | Increase (Decrease) in Employee Related Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $975.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.41M 10-Q · filed 2026-08-05 | -$1.53M derived: sum of 3 quarters · filed 2026-08-05 | -$561.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$2.38M 10-Q · filed 2026-05-06 | -$2.50M derived: sum of 2 quarters · filed 2026-05-06 | -$1.54M derived: sum of 3 quarters · filed 2026-05-06 | -$1.44M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $847.00K derived: sum of 2 quarters · filed 2026-03-04 | $948.00K derived: sum of 3 quarters · filed 2026-08-05 | -$3.61M 10-K · filed 2026-03-04 |
| 2025-09-30 | $965.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.07M derived: sum of 2 quarters · filed 2026-08-05 | -$3.49M 10-Q · filed 2025-11-06 | -$1.70M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $101.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$4.45M 10-Q · filed 2026-08-05 | -$2.66M derived: sum of 3 quarters · filed 2026-08-05 | -$168.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$4.55M 10-Q · filed 2026-05-06 | -$2.76M derived: sum of 2 quarters · filed 2026-05-06 | -$269.00K derived: sum of 3 quarters · filed 2026-05-06 | $1.10M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $4.29M derived: sum of 2 quarters · filed 2026-03-04 | $5.65M derived: sum of 3 quarters · filed 2026-03-04 | $5.15M 10-K · filed 2026-03-04 |
| 2024-09-30 | $2.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $3.86M derived: sum of 2 quarters · filed 2025-11-06 | $3.36M 10-Q · filed 2025-11-06 | $2.39M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $866.00K 10-Q · filed 2025-08-07 | -$106.00K derived: sum of 3 quarters · filed 2025-08-07 | -$325.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$501.00K 10-Q · filed 2025-05-08 | -$1.47M derived: sum of 2 quarters · filed 2025-05-08 | -$1.69M derived: sum of 3 quarters · filed 2025-05-08 | -$930.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$972.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$1.19M derived: sum of 2 quarters · filed 2025-03-07 | -$429.00K derived: sum of 3 quarters · filed 2025-03-07 | -$2.82M 10-K · filed 2025-03-07 |
| 2023-09-30 | -$219.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $543.00K derived: sum of 2 quarters · filed 2024-11-07 | -$1.85M 10-Q · filed 2024-11-07 | -$2.49M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $762.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | -$1.63M 10-Q · filed 2024-08-02 | -$2.27M derived: sum of 3 quarters · filed 2024-08-02 | -$567.00K derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | -$2.39M 10-Q · filed 2024-05-06 | -$3.04M derived: sum of 2 quarters · filed 2024-05-06 | -$1.33M derived: sum of 3 quarters · filed 2024-05-06 | $1.10M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | -$642.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $1.06M derived: sum of 2 quarters · filed 2024-03-13 | $3.49M derived: sum of 3 quarters · filed 2024-03-13 | $1.36M 10-K · filed 2024-03-13 |
| 2022-09-30 | $1.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $4.13M derived: sum of 2 quarters · filed 2023-11-07 | $2.01M 10-Q · filed 2023-11-07 | $3.35M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $2.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $299.00K 10-Q · filed 2023-08-07 | $1.65M derived: sum of 3 quarters · filed 2023-08-07 | $2.20M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | -$2.13M 10-Q · filed 2023-05-08 | -$780.00K derived: sum of 2 quarters · filed 2023-05-08 | -$224.00K derived: sum of 3 quarters · filed 2023-05-08 | $1.63M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $1.91M derived: sum of 2 quarters · filed 2023-03-16 | $3.76M derived: sum of 3 quarters · filed 2023-03-16 | $1.92M 10-K · filed 2023-03-16 |
| 2021-09-30 | $556.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $2.41M derived: sum of 2 quarters · filed 2022-11-10 | $569.00K 10-Q · filed 2022-11-10 | $1.83M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $1.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $13.00K 10-Q · filed 2022-08-11 | $1.28M derived: sum of 3 quarters · filed 2022-08-11 | $2.22M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$1.84M 10-Q · filed 2022-05-10 | -$579.00K derived: sum of 2 quarters · filed 2022-05-10 | $366.00K derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $2.21M derived: sum of 2 quarters · filed 2022-03-24 | $1.90M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $945.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $634.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$311.00K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |